BSEAGM/EGM1d ago · 23 Sept 2026, 04:57 pm

Summary of Proceedings of 41st Annual General Meeting of the company held on Wednesday, 23rd September 2026 pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Biofil Chemicals & Pharmaceuticals Ltd · 524396

✦ AI Summary

Biofil Chemicals & Pharmaceuticals Ltd held its 41st Annual General Meeting (AGM) on September 23, 2026, through video conference. The meeting was attended by 42 members, and the requisite quorum was present. The company secretary briefed the members on the participation through VC/OAVM and informed them about the remote e-voting process. The chairman delivered his opening remarks on the company's performance and future positioning. The meeting transacted two items of business, including the adoption of audited financial statements and the appointment of a director.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Biofil Chemicals & Pharmaceuticals Ltd - 524396 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Attachments (1)

📄

c6a96113-1eeb-4a7b-8dc0-12f5a455aac6.pdf

pdf

Download →
View document text
BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED CIN: L24233MP1985PLC002709 Registered Office: B/12-B, Industrial Estate, Pologround, Indore-452015 (M.P.) Tel. 0731-2426700; Email id- bcplcompliance@gmail.com; Website- www.biofilgroup.net; Fax: 0731-2426700 Date: 23rd September, 2026 To, To, The Company Secretary, The Company Secretary Corporate Compliance Department Corporate Compliance Department National Stock Exchange of India Limited BSE Limited Bandra Kurla Complex, Mumbai Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai Sub: Summary of Proceedings of 41st Annual General Meeting of the Company held on Wednesday, 23rd September, 2026 pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. Reference: BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED (BSE Scrip Code: 524396; NSE SYMBOL: BIOFILCHEM; ISIN: INE829A01014) Dear Sir/Madam, This is to inform that the 41st Annual General Meeting (AGM) of the Company was held today, i.e. Wednesday, 23rd September, 2026 through Video Conference (VC) / Other Audio Visual Means (OAVM) in accordance with the relevant circulars issued by the Ministry of Corporate Affairs, Government of India and the Securities and Exchange Board of India. The meeting commenced at 03:03 P.M. (IST). The Registered office of the Company has been deemed as the venue for the Meeting and the proceedings of the 41st Annual General Meeting have been deemed to be made thereat, to transact the businesses as stated in the Notice dated 11th August, 2026 convening the 41st AGM, without the physical presence of the Members at a common venue. The following Directors and KMP’s were present at the meeting: S. No. Name of the Director Designation 1 Mr. Ketan Shah Chairman & Managing Director 2 Mr. Meet Shah Non Executive Director 3 Mr. Smitesh Shah Non Executive Director 4 Mr. Ashok Kumar Ramawat Independent Director 5 Mr. Satish Beohar Independent Director 6 Mrs. Gayatri Padiyar Independent Director Chairperson of Audit, NRC and SRC Committee 7 Mr. Apoorv Jain Company Secretary and Compliance officer 8 Mr. Pavan Singh Rajput Chief Financial Officer Total Members as on Cutoff date 16th September, 2026:- 25125 Members Present: 42 Members have attended the meeting through video conference (VC)/ other audio-visual means (OAVM). Mr. Apoorv Jain, Company Secretary & Compliance Officer, introduced Directors and Senior Management Personnel’s present at the meeting through VC/OAVM. The respective Chairperson of the Audit Committee, Stakeholders Relationship Committee and Nomination and Remuneration Committee were also present at the AGM. The Statutory Auditors, Secretarial Auditors and scrutinizer were also present at the Meeting through VC/OAVM. The requisite quorum being present, the company secretary with the permission of chair, called the meeting in order. The Company Secretary then briefed them on certain points relating to the participation at the Meeting through VC/OAVM. He also informed that the meeting was held through VC/OAVM in compliance with the circulars issued by the Ministry of Corporate Affairs, Government of India and Securities and Exchange Board of India as amended from time to time. Since there was no Physical attendance of Members and in compliance with the various circulars issued by the MCA and SEBI, the requirement of appointing proxies was not applicable, except for the authorized representatives of corporate shareholders. Further, the Registers as required under the Companies Act, 2013 and other relevant documents mentioned in the Notice were available for inspection in electronic mode. Also, He informed that the remote e-voting commenced at 9.00 A.M. (IST) on Sunday, 20th September, 2026 and concluded at 5.00 P.M. (IST) on Tuesday, 22nd September, 2026. Mr. Ketan Shah Chairman and Managing Director of the Company, Chaired the meeting. The Chairman thereafter delivered his opening remarks on the Company’s performance, summary on Company’s performance in Fiscal Year 2026 and its future positioning. The Company Secretary then invited the members to express their views, offer suggestions and raise queries concerning the operations, financial performance and other related matters of the Company. A total of four registrations were received from members who had expressed their desire to speak at the meeting. However, only one registered speaker raised queries during the meeting. The Company Secretary informed the speaker that the queries and concerns raised by him would be duly addressed and that the requisite responses would be communicated to him through email. Thereafter the Company Secretary informed the Members that the Notice convening the 41st AGM and the Annual Report for the financial year ended 31st March 2026 was circulated electronically to the members of the Company. The Reports of the Statutory Auditor on the financial statements did not contain any qualification or adverse remarks and hence were not required to be read. Further observation made by secretarial auditor of the Company in their report is self explanatory and shall not have any adverse effect on the functioning of the Company. In terms of the Notice dated 11th August, 2026 convening the 41st AGM of the Company, the following items of businesses were transacted at the Meeting:- [Method of voting for the Resolutions: Remote e-voting and e-voting at the AGM] Item Details of Agenda Items Resolution Required 1. To consider and adopt the Audited Financial Ordinary Statements of the Company together with the Report of the Board of Directors and the Auditors thereon for the financial year ended March 31, 2026. 2. To appoint a Director in place of Mr. Smitesh Shah (DIN: Ordinary 00326182) who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible offers himself for re-appointment. 3. Continuation of directorship of Mr. Ashok Kumar Special Ramawat (DIN: 08818263) as a Non-Executive Independent Director of the Company on attaining the age of 75 (seventy-five) years. 4 Approval of Material Related Party Transaction(s) with Ordinary Cyano Pharma Private Limited. Thereafter the Company Secretary thanked the Members for continuing support and for attending the Annual General Meeting and requested the Members to continue e-voting for next 15 minutes. Ms. Darshika Wankhede, Practicing Company Secretary was authorized to scrutinize remote e-voting process and e-voting during the AGM. 41st Annual General Meeting of the Company was concluded at 03:17 P.M. (IST) by the Company Secretary with the permission of the Chair. MANNER OF APPROVAL:- 1. As per the provisions of the Companies Act, 2013 and Regulation 44 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, the Company had provided the remote e-voting facility to enable the members to cast their votes electronically on all the resolutions set out in the Notice of 41st Annual General Meeting. The Meeting was conducted in accordance with the provisions of the Companies Act, 2013, read with circulars and notifications issued by Ministry of Corporate Affairs (MCA) and Securities and Exchange Board of India (SEBI) as amended from time to time. 2. Further the Company had provided facility of e-voting during the 41st Annual General Meeting to the members present in the meeting through VC/OAVM and who had not casted their vote(s) on the resolutions through remote e-voting facility. Further, copy of voting results of AGM in the format specified by the SEBI along with Scrutinizer’s Report will be submitted within time limit as prescribed in Regulation 44(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and record. Thanking You, Yours Faithfully, FOR, BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED APOORV JAIN COMPANY SECRETARY & COMPLIANCE OFFICER M.No: A71739